Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Peter Davis reposted
UCLA Neurology
@UCLANeurology
The UCLA Brain Tumor Center is hosting the 24th Annual UCLA Brain Tumor Conference on Friday, May 10, and Saturday, May 11!
Join patients & healthcare professionals at this free conference to hear the latest news on brain tumors, resources, and more! http://uclahealth.org/braintumor
Why don't you either learn english, so that I didn't have to worry about whether you actually can read, or learn to comprehend, so I didn't have to repeat myself over and over, OR you just confirm you are a paid shill who just have no interest in acknowledging what I say, but to make me run in circles according to you paid lots goals for creating fud and disinformation?
And you were martyDg on X I guess, now blocked for incessant bullshitting. Figures. The desperate rhetoric, I ought to have known.
I HAVE posted about NWBO being late and not compliant with their current ASM. It's inherent in the fucking history lesson about 10 years of harassment against NWBO, which you lot have no interest in acknowledging have happened and thus not the consequences hereof. I have posted time and time again, WHY they have chosen to remain silent and await with information, till they decide its the right moment. We know you guys are desperate for events or info you can make up new distorted fud narratives for.
What toxic financing? The TERMS of loans decide whether there's talk of toxic financing.
Here ... for your viewing pleasure. The loans LP have gotten are NOT toxic.
Congratulations on your many purchases of NWBO!
Popping bottles soon!
Thanks for the post!
I assume you have champagne ready for the celebration!
Legend, TDD is real. Your posts are total BS.
In the PR in 2016 on the collaboration trial between Merck and NWBO, LP said the trial took more than 2 years of planning and work. The PI of the collaboration trial was Markus Moehler. I went through some of his publications between 2013 and 2023 to see if he had been in contact with Merck. I suspect if there are still some people who claimed that this trial never happened. The collaboration between Markus Moehler and Merck reminds me of the interaction between Vivek Subbiah and NWBO.
Danish dud says he posts factual info but only the fact he wants to post
Why not post about NWBO being late and not compliant with their current ASM??
Why not post about their toxic financing?
Why not post about their stock being down 71% in the last 2 years but up 40% in the last 5 years. Makes no sense to your spoofing claims since NWBO says in their lawsuit the MM’s have been spoofing from 2017-2022 when in that period the stock was also positive.
Tell me your definition of exwannabe, learningcurve2020, legend431, iclight, inquiriq and "the like"?
— 🇩🇰 The Danish Dude 🇩🇰 (@FlemmingBruce) May 3, 2024
You can call me a shill and a pumper as much you want.
I provide factual information you have no ability to refute, and I know you're shorter/paid shill.
Good enough for me.
Hey Hope, I tuned in. Could you share your thoughts on it? One positive aspect about Linda Liuv is her commitment to honesty without embellishment. She genuinely shared what they discovered. From what I grasped, in simpler terms, DCVAX appears to work better than current standard of care process, with around 20% of those who received it surviving or continuing to survive beyond five years. If MHRA or FDA were to approve DCVAX sooner, it could not only benefit people but also make it more feasible to explore combination therapies.
I value genuine expressions of opinions from everyone and I believe understanding others' perspectives is also a component of due diligence.. The reason for adding certain users to the ignore list is because they persistently engage in arguments with people who have invested in the company. While I can't confirm if they're being compensated for their posts, it raises the question "why would someone continuously post messages when most investors aren't interested?" There seems to be a motive behind it.
Well if it was about trial integrity , they had ample time to disclose that after the trial was over . It has been years since the trial has been over , data locked and results published . And they know that shareholders had been asking for the reason and shorters have used the silence against the company . So it defies the logic that if trial integrity was the reason , they didn’t still disclose it to put the questions to rest .
That’s because she is worth it!
I dont like what you are doing to this board, but must admit, you made me laugh on this one, good one!!!
It reminded me the Jimmy Kemmel snippet on Trump/Obama comparaison.
You had both side (pro-anti Trump) sharing it and laughing their ass off!!!
(I though some regular user had a death in their familly, and you were offering your condoleance, so click the post you were replying to, and yeah, good one)
But important in terms of proper governance exhibited, yes?
LC,the never ending poster. All Day,,,,Every Day
I have been buying for years. My first NWBO stock purchase was many many moons ago when the stock was around $10's a share. Then the big money rat bastards moved in and manipulated the price under $1 driving the company off the nasdaq in 2016. I continued to buy all the way down until the stock was under 20 cents. I learned long ago when everyone else is selling it is when you want to buy. I picked up most of my shares around 20 cents. I didn't buy too much as the price went up from 20 cents but did on occasion when the big money rat bastards manipulated it lower. My main criteria was that I only bought when my average purchase price dropped further. I had a limit order for several weeks before it kicked in about a week ago. I put in another lower limit order that almost kicked in this past week but didn't yet. We can all see the light at the end of the tunnel now so we're either going to get approval and the stock price start to really sky rocket or find these big money rat bastards have their claws into the approval agencies and tank things . . . hopefully the world hasn't become so corrupt that a revolutionary industry disruptive treatment such as DCVAX that is pretty much a cure for 20-30% of brain cancer patients that really have no effective treatment can be prevented from coming to fruition but when one looks around at the world with all the rat bastards doing unbelievably horrible things without consequence it leaves one wondering. Best of luck to those invested in NWBO and more importantly to all those cancer patients that really have no effective treatment today.
attilathehunt,
There is a point in the development process where formal validation must still occur but is really mostly just a formality where an entire fitting out is done inspected and approved for commercial use. The original product is basically green lighted much earlier. We have the green light based on the actions NWBO is taking but the fitting out still takes a while as explained in the PR about components of the clean rooms having long lead times. Afterwards comes final inspection. In the mean time, the B grade clean rooms can be used for initial commercialization purposes which is what the MIA was based on and likely where comparability/equivalence tests were performed. Best wishes.
Well Newman first I don't have 7 uncles an no it did not take 4 weeks, seems you are making things up. I ask again for you to listen to the Liau presentation and tell the board what you hear. Just for the record I have been long for over 9 years and read every paper by Liau and Prins and listened to all of their presentations that I know of. Their claims on dcvax pretty much remain the same. Did you listen to the presentation that was linked today (even if as it turns out was from last year)?
learningcurve2020,
The summary was in the first sentence and you saw that. The rational took the rest. Your response explains quite a bit; ). Best wishes.
I refuse to read all this because the most likely explanation should take place in a sentence or two.
learningcurve2020,
The screening hold silence was likely about trial integrity and keeping some folks with their own ideas at bay with non disclosed information in my opinion, not a self inflicted wound. I believe long term data could have been affected by disclosing the reason for the hold as patients would have wanted to immediately cross over from SOC/placebo and no finalized plan for the SAP had been created or accepted by regulators. Then there is the explanation about need to develop manufacturing over an indeterminate amount of time would have led to investors pulling out not increased buying from investor satisfaction with the disclosure. You know this but refuse to acknowledge this because it is not fit for purpose with regard to your overall stance with regard to NWBO management.
Dilution would have been significantly greater with these disclosures and I believe even more activity with regard to share price manipulation or attempts to interfere with management plans to maintain ownership of the platform value in the hands of NWBO investors and not others would have occurred. This could have led to the point of potential bankruptcy or very cheap buyout if investors had known manufacturing was the holdup and bad actors were allowed to play with retail pretending to be rescuers for their own purpose. Linda asked for manufacturing help in 2018 and many investors thought that was a desperate move. How many would have sold out to the highest bidder over $3 back then knowing that manufacturing was going to be held up? Obviously many investors would have bailed or at least traded more in the interim looking for a better price and greater ROI had they known how long this would take and that would have created even more dilution.
There are several big investors and some smaller ones who likely have been trading in and out in order to increase their holdings or value of their investment over time. Those who help finance certainly know how to make money in the interim or minimize risk when shares and warrants have been part of the deal. Can’t wait to see the platform value move into the hands of long term retail investors as Linda seems to have planned for. Best wishes.
For me the fascinating aspect in all this are the Advent partners that must toast every night. ...The Cognate execs who walk the beach and dawn. Simply amazing the transfer.
Bought 800,0000 + 10,000 + 200,000,000. I'm da man!!!
You forgot to mention the CDMO owned by her et.al.
you forgot to add that all this benefits are for the CDMO not owned by the company But by the CEO's own fund......so convenient and so absolutely a related party. Go look in their SEC filings and see for yourselves.
Such garbage.....it's why SEC booted them out and they didn't fight it. You pay for what you get and this is OTC garbage. See FUD below right on the SEC website. LMFAO. Nothing to see here, they still can't file on time (see latest 10-K) or hold a timely ASM. You running out of eye rolls here.
https://www.sec.gov/enforce/34-87281-s
The company just keeps making “advancements” and “build outs” for a product not guaranteed……..in a building they don’t own……..multiple, infinity, continuous, borrowing, and out of eye rolls zzzzzzzzz……..building all this chit but NO approved product. Just building another facility….hmmmmmmmmmm…….read between the lineszzzz……out of eye rollszzzzz……sucker galore on this board!!!!!!
Pumpernickel YuYU…….. LaLAAAAA….. YuLAYuLAYuuuuuuuuuuuuuuuuuu…………..AAAAAAAAAAAAAAAAAAAWWWWHHHHHOOOOOOOOOOOOOOoooooooooooeeeeeee!!!!!!!!
Bought 5000 more at the beginning of the week. Never wanted the amount I have now but feel I have no choice. I was one of the ones who started buying at a buck. I have little shares compared to the rest of you but to many for my liking.
No wonder you are able to buy cheaper after 4 weeks since you sold because your 7 uncles are playing the holding pattern which is equal to the Robinhood's famous one day play during the AMC/GME Reddit SQ; that RH customers can only sell - can't buy. The same fing pattern ur 7 MM uncles are playing in the last 6 months here, imo. All the selling is from them induced and imposed on the poor retails. Not many buys at all; all those robbed shares are channeled to you shorts and suckers and the ugly hfs. Well, I am waiting for the June 14th to come!
These people are clueless or disciples.
No. You’re trying to confuse potential investors and I clarified.
I like when people are concise and say what they mean. You could make your same statement about NVCR management and it would have a different meaning, because they are truly dumping their own personal shares over the last 5 years.
Norisk, have you actually listened to the presentation from Dr Liau? Tell us what you think it says. Any by the way you can also criticize me as I did sell some shares of nwbo to purchase another stock while waiting for some $ to be transferred. Later bought those nwbo shares back once the $ came in and was able to get them 10 cents lower than I had sold. You seem to be critical of anyone doing such things.
Yea.... BAM baby! woo hoo
$zero soon
OK, I see where you're coming from. Bam! one way or the other in my book.
For my eyes only, or not. For the record, Hopeforthefuture3's post 688770 is invisible to me also even though not on ignore. The only reason I know is via someone's response to him.
When you can just print more for free, it doesn't really matter.. Does it?
Hank Your about the only one with common sense. He's probably new to investing doesn't know how things work.
LP takes 5 X the average CEO annual salary! Without her stock and bonuses!
<<< $165,598/ year Avg. Base Salary (USD) >>>
https://www.payscale.com/research/US/Job=Chief_Executive_Officer_(CEO)/Salary
Suckers
And how many has she bought in last 10 years
He obviously meant selling as president on behalf of NWBO to investors, such as for warrant exercise and PP. He did not mean selling her own shares in NWBO.
Linda hasn’t sold any of her shares in well over five years.
Maybe we'll get another one of those 100 share buys after hours in the .80's
Something weird going on w my ihub. The only way I can see your post is via Mani's response to you. I recently saw another post from you discussing the 8k and I confirmed you are not on ignore. When I go to the listing of posts in Classic view there is a post at 11:04 and 11:06AM but not your post at 11:05. I thought this happened w another poster too but thought I messed up but after quadruple checking, I don't think so.
Don't expect either.
You will experience more disappointment
Advent sites Advent Bioservices began activity as a cell therapy Contract Development & Manufacturing Organisation (CDMO) in 2016. We are currently managing the development of a state-of-the-art facility for multiproduct Good Manufacturing Practice (GMP) production outside Sawston in Cambridgeshire, which will allow scale up of current commercial production and initiate the provision of contract manufacturing services to meet the growing demand for such services in the UK.
The Sawston facility is perfectly positioned in the ‘UK golden triangle’ for cell and gene therapy, our facility is located just 7 miles outside Cambridge city centre with excellent transport links to Central London, London Stansted airport and it is 4 miles from the M11 motorway, linking to the Midlands by the new A14 extension.
The facility consists of 2 separate GMP suites with grade B/C classified areas, in house QC testing, process development laboratories, warehouse and office space as well as a multipurpose cold storage and cryogenic storage unit.
We operate the facility under a comprehensive IT infrastructure including EMS, eQMS eBMR and LIMS systems with secure storage for client documents and paperless systems. Our cleanroom suites are fully validated, with an in-house environmental monitoring system. Clients utilising our manufacturing service will benefit from ancillary services and technical support inclusive of process development, QC and validation. Ultra-cold and cryogenic facilities are available to external clients as off-site storage and are fully GMP compliant.
.
Worthless post, doesn’t matter what he thinks Eden’s and Advent are worth.
What does matter is nwbo proceeds with automated mfg as if MHRA approval is expected.
Waiting for the approval cement on your ankles ….LoL
It'll still need certification and approval.
No, just pushes aside the shot piled on the stock for years.
You could say the same for approval by regulatory agencies in your world. Quite frequently approval leaves a stock flat or even going down these days, but the undeniable fact is, that company has gone from pre-revenue to commercial. The best example I can give is Regeneron. After approval it stayed flat for around a year. Was it irrelevant that the FDA approved what became their most important drug approval? Obviously NOT.
The markets are often off, misinformed and unable to judge the future because of shorts and their immense work to misinform the market.
Big events that change the narrative of a drug and company can be something a stock market might not note but every competitor and potential partner might take immense interest in and that can open the door to negotiations that can be quiet, take a while and change the false direction of things that had been set by false narratives told over and over and over again by interests and people who had contrary interests and far more immediate resources.
Followers
|
1621
|
Posters
|
|
Posts (Today)
|
5
|
Posts (Total)
|
688916
|
Created
|
02/02/05
|
Type
|
Free
|
Moderators XenaLives sentiment_stocks CaptainObvious Poor Man - Doc logic JerryCampbell |
“Now this is not the end. It is not even the beginning of the end. But it is, perhaps, the end of the beginning.”
~ Winston Churchill
Stylized Dendritic Cell featured on NWBO board since 2015
- Dr. Linda Liau, PhD, MBA, Professor and Chair, Department of Neurosurgery, David Geffen School of Medicine at UCLA
Clinical Trials
DCVax®-L to Treat Newly Diagnosed GBM Brain Cancer (NCT00045968) - Phase III (Double Blind)
UK (MHRA): DCVax-L to Treat Newly Diagnosed GBM Brain Cancer (EudraCT#) 2011-001977-13
DE (Germany - PEI): DCVax-L to Treat Newly Diagnosed GBM Brain Cancer (EudraCT#) 2011-001977-13
Expanded Access Protocol for GBM Patients with Already Manufactured DCVax®-L Who Have Screen-Failed Protocol 020221 (NCT02146066) (Expanded Access)
Safety and Efficacy Study of DCVax-Direct in Solid Tumors (NCT01882946) - Phase I/Phase II (Open Label)
UK Clinical Trials - Study of a Drug (DCVax®-L) to Treat Newly Diagnosed GBM Brain Cancer
EU Clinical Trials for DCVax-L - Phase III
Dendritic Cell Vaccine for Patients with Brain Tumors (NCT01204684) - Phase II - at UCLA - Randomized (Open Label) testing DCVaccine with Resiquimod and DC Vaccination with Adjuvant polyICLC
Pembrolizumab and a Vaccine (ATL-DC) for the treatment of Surgically Accessible Recurrent Glioblastoma - Phase 1 (NCT04201873)
Dendritic Cell-Autologous Lung Tumor Vaccine (DCVax-L) and Nivolumab in Treating Patients with Recurrent Glioblastoma - Phase 2 (NCT03014804)
Dendritic Cell Therapy for Brain Metastases From Breast or Lung Cancer (NCT0368765) - Phase 1 - Collaborator: Mayo Clinic
Announcement of DCVax-L and Anti-PD-1 Monoclonal Antibody (Pembrolizumab) for Patients with Liver Metastases of Primary Colorectal Carcinoma Phase 2 Trial - November 17, 2016 - University Medical Center (UMC) of the Johannes Gutenberg University of Mainz
Cognate Bioservices - Owned by Charles River Labs
Website
Company Contact Info
Investor Relations:
Les Goldman (Company) (202) 841-7909 lgoldman@nwbio.com
Sign up for Northwest email list here (hit the subscribe to email list button in the lower right)
Company Headquarters
4800 Montgomery Lane, Suite 800, Bethesda, MD 20814 (240) 497-9024
NW Bio is developing cancer vaccines designed to treat a broad range of solid tumor cancers more effectively than current treatments, and without the side effects of chemotherapy drugs. NW Bio’s proprietary manufacturing technology enables them to produce its personalized vaccine in an efficient, cost-effective manner. NW Bio has a broad platform technology for DCVax dendritic cell-based vaccines.
Their lead product, DCVax-L, is currently in a 331-patient Phase III trial for patients with newly diagnosed Glioblastoma multiforme (GBM), the most aggressive and lethal brain cancer. This trial is currently underway at 69 locations thoughout the United States, Germany and the United Kingdom. NW Bio has also conducted a Phase I/II trial with DCVax-L for late stage ovarian cancer together with the University of Pennsylvania.
Their second product, DCVax-Direct, is currently in a 60-patient Phase I/II trial for direct injection into all types of inoperable solid tumor cancers, with trials currently being conducted at both MD Anderson Cancer Center in Texas, as well as Orlando Health in Florida.
They previously received clearance from the FDA for a 612-patient Phase III trial with its third product, DCVax-Prostate, for late stage prostate cancer.
DCVAX Survival Stories & Testimonials
Alice - Metastic Merkel Cell patient from Florida - ASCO 2018
Brad Silver - GBM patient from Huntington Beach, California - ASCO 2018
Sarah Rigby - GBM patient from Hong Kong - ASCO 2018
Kristyn Power - daughter of GBM patient from Canada - ASCO 2018
Kat Charles - GBM patients from UK - ASCO 2018 - as related by her husband Jason (Kat's Cure)
Prospective patients may contact NW Bio at patients@nwbio.com
UCLA Jamil Newirth DCVax-Patient Video - 2015
Allan Butler Video - National Geographic Vice President - DCVax-Direct patient from Phase 1 Trial with Pancreatic Cancer
NWBO - Patients Sunday Dennis and Jami Newirth - Enrolled at UCLA - Vimeo, Uploaded approx. May 2015
NWBO - Vaccine Helps Keep Brain Cancer Patient Alive (Jennifer Sugioka) - NBC Channel 4, Southern California, February 24, 2015
NWBO - National Geographic's Allan Butler Stage IV Pancreatic Patient using DCVax-Direct at MD Anderson
NWBO GBM Brain Cancer Survival Story of Mark Pace
Presentations
UCLA Agreements
Prostrate
DCVax-Phase II
DCVax-Booster
Upcoming Events
Videos
Linda M. Liau, MD, PhD, MBA - April 24, 2019 at University of Washington, Neurosciences Institute
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |